CTI BioPharma
CTIC
#5642
Rank
HK$9.31 B
Marketcap
HK$70.63
Share price
0.00%
Change (1 day)
30.83%
Change (1 year)

Market capitalization of CTI BioPharma (CTIC)

Last known market cap: HK$9.31 Billion

On August 25, 2023 CTI BioPharma had a market cap of HK$9.31 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CTI BioPharma from 2001 to 2023

End of year Market Cap

Year Marketcap Change
2023HK$9.36 B57.13%
2022HK$5.95 B218.67%
2021HK$1.86 B-1.3%
2020HK$1.89 B165.55%
2019HK$0.71 B114.18%
2018HK$0.33 B-62.97%
2017HK$0.89 B0.83%
2016HK$0.89 B-66.63%
2015HK$2.67 B-17.37%
2014HK$3.23 B50.14%
2013HK$2.15 B94.74%
2012HK$1.10 B-36.28%
2011HK$1.73 B-24.86%
2010HK$2.31 B-55.7%
2009HK$5.21 B8149.25%
2008HK$63.24 M-91.61%
2007HK$0.75 B-61.73%
2006HK$1.96 B62.13%
2005HK$1.21 B-68.55%
2004HK$3.86 B68.99%
2003HK$2.28 B23.28%
2002HK$1.85 B-70.82%
2001HK$6.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
HK$1.393 T 14,854.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$864.34 B 9,178.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
HK$152.72 B 1,539.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$77.41 B 731.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.507 T 80,494.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$284.29 B 2,951.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$2.075 T 22,177.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland